Yahoo Web Search

Search results

1. • 

     Chimerix (CMRX) Upgraded to Buy: What Does It Mean for the Stock?

     Zacks via Yahoo Finance· 1 year ago

     Chimerix (CMRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2...

2. • 

     Chimerix (CMRX) Loses -24.68% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

     Zacks via Yahoo Finance· 1 year ago

     Chimerix (CMRX) has become technically an oversold stock now, which implies exhaustion of the heavy...

3. • 

     Chimerix (CMRX) Earnings Expected to Grow: What to Know Ahead of Q3 Release

     Zacks via Yahoo Finance· 2 years ago

     Chimerix (CMRX) possesses the right combination of the two key ingredients for a likely earnings...

4. • 

     Chimerix (CMRX) Beats Q3 Earnings Estimates

     Zacks via Yahoo Finance· 1 year ago

     Chimerix (CMRX) delivered earnings and revenue surprises of 30.95% and 84.14%, respectively, for the quarter ended September 2022. Do the numbers hold...

5. • 

     Here's Why Chimerix Stock Is Imploding Today

     Motley Fool· 2 years ago

     What happened A poorly received decision from the management team at Chimerix (NASDAQ: CMRX), a biopharmaceutical company, sent its stock price into a...

6. • 

     7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher

     InvestorPlace via Yahoo Finance· 2 years ago

     Monkeypox stocks, our topic for today, have had a mostly mixed performance so far in 2022. It is...

7. • CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.

     InvestorPlace via Yahoo Finance· 9 months ago

     Chimerix (NASDAQ:CMRX), like most clinical-stage biotech stocks, is without question a high-risk play. Yet in contrast to other biotechs, where high potential rewards can outweigh this high ...

8. • 

     Implied Volatility Surging for Chimerix (CMRX) Stock Options

     Zacks via Yahoo Finance· 2 years ago

     Investors in Chimerix, Inc. CMRX need to pay close attention to the stock based on moves in the...

9. • 

     Chimerix (CMRX) Plunges on Unfavorable Pipeline Updates

     Zacks via Yahoo Finance· 2 years ago

     The development of Chimerix's (CMRX) lead candidate, ONC201, gets delayed as the FDA states that...

10. • 

      Charles River (CRL) to Report Q3 Earnings: What's in Store?

      Zacks via Yahoo Finance· 2 years ago

      Charles River Laboratories International, Inc. CRL is scheduled to report third-quarter 2022 results...